Home › Stocks › SLXN

SLXN — SILEXION THERAPEUTICS CORP

Reported value held$307.52K
Funds holding (latest)17
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q2 2026)6
Institutional value$42.79K · 17.12K sh
New / Add / Cut / Exit2 / 1 / 3 / 3 · Updated 2026-11-13
Top-5 / Top-10 concentration100.0% / 100.0%
Institutional holdings change Reducing -54.9% (-2.12K sh)
Institutional value change Down -10.1%

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

As of Q2 2026, 6 SEC-registered investment managers reported holding SLXN (SILEXION THERAPEUTICS CORP) in their latest 13F filings, with a combined reported value of $42.79K across 17.12K shares. That is -54.9% by share count (-2.12K shares) versus the previous quarter, while reported value moved -10.1%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 2 opened new positions, 1 added to existing stakes, 3 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.

Major shareholders of SILEXION THERAPEUTICS CORP (SLXN) include Wildcat Capital Management, LLC, Warberg Asset Management LLC, HRT FINANCIAL LP, ranked by reported 13F value among the 17 institutional holders on this page.

SLXN is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 7 315.60K $86.92K +1016.3%
Q2 2026 6 17.12K $42.79K -54.9%
Q1 2026 7 36.48K $46.69K +35.5%
Q4 2025 6 18.32K $35.16K +19.6%
Q3 2025 4 5.08K $17.29K -98.6%
Q2 2025 7 298.07K $241.88K +15.4%
Q1 2025 5 236.18K $259.80K +45.2%
Q4 2024 3 140.17K $280.85K -87.6%

Over the 8 quarters shown, institutional share counts increased 125% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q3 2025 (-98.6%).

Top Institutional Holders (Q3 2026) — 7 funds

FundSharesValuePortfolio WeightChange
Warberg Asset Management LLC 225.46K $61.93K 0.01% New
JANE STREET GROUP, LLC 72.49K $20.10K 0.00% New
UBS Group AG 17.45K $4.83K 0.00% Add
BFC Planning, Inc. 133 $37 0.00% Hold
Pflug Koory, LLC 33 $9 0.00% Hold
JPMorgan Chase & Co 21 $7 0.00% New
SBI Securities Co., Ltd. 14 $4 0.00% Add

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 6 funds

FundSharesValuePortfolio WeightChange
HRT FINANCIAL LP 15.24K $38.00K 0.00% New
UBS Group AG 1.41K $3.60K 0.00% Add
MONTAG A & ASSOCIATES INC 300 $765 0.00% Reduce
BFC Planning, Inc. 133 $339 0.00% New
Pflug Koory, LLC 33 $84 0.00% Reduce
SBI Securities Co., Ltd. 2 $5 0.00% Reduce

Q1 2026 — 7 funds

FundSharesValuePortfolio WeightChange
Citadel Advisors 20.93K $26.79K 0.00% Add
TWO SIGMA SECURITIES, LLC 11.66K $14.92K 0.00% New
MONTAG A & ASSOCIATES INC 3.00K $3.84K 0.00% Hold
UBS Group AG 517 $662 0.00% Reduce
Pflug Koory, LLC 333 $426 0.00% Hold
JONES FINANCIAL COMPANIES LLLP 26 $32 0.00% Hold
SBI Securities Co., Ltd. 20 $26 0.00% Reduce

Q4 2025 — 6 funds

FundSharesValuePortfolio WeightChange
Citadel Advisors 12.21K $23.43K 0.00% New
MONTAG A & ASSOCIATES INC 3.00K $5.76K 0.00% Hold
UBS Group AG 1.69K $3.25K 0.00% Add
SBI Securities Co., Ltd. 1.06K $2.04K 0.00% Hold
Pflug Koory, LLC 333 $639 0.00% Hold
JONES FINANCIAL COMPANIES LLLP 26 $50 0.00% New

Q3 2025 — 4 funds

FundSharesValuePortfolio WeightChange
MONTAG A & ASSOCIATES INC 3.00K $10.20K 0.00% New
SBI Securities Co., Ltd. 1.06K $3.60K 0.00% Reduce
UBS Group AG 692 $2.35K 0.00% Reduce
Pflug Koory, LLC 333 $1.13K 0.00% New

Q2 2025 — 7 funds

FundSharesValuePortfolio WeightChange
Wildcat Capital Management, LLC 113.43K $91.88K 0.06% Hold
UBS Group AG 109.26K $88.50K 0.00% Add
MEYER HANDELMAN CO 32.97K $26.70K 0.00% Hold
SBI Securities Co., Ltd. 16.41K $13.29K 0.00% Hold
Virtu Financial LLC 14.26K $12.00K 0.00% New
StoneX Group Inc. 11.24K $9.11K 0.00% New
Bank of America Corp 500 $405 0.00% Hold

New Positions (Q2 2026)

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 17 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Warberg Asset Management LLC 225.46K — — — — — — — —
JANE STREET GROUP, LLC 72.49K — — — — — — — —
UBS Group AG 17.45K 1.41K 517 1.69K 692 109.26K 72.87K 14.85K 15.06K
BFC Planning, Inc. 133 133 — — — — — — —
Pflug Koory, LLC 33 33 333 333 333 — — — —
JPMorgan Chase & Co 21 — — — — — — — —
SBI Securities Co., Ltd. 14 2 20 1.06K 1.06K 16.41K 16.41K — —
Wildcat Capital Management, LLC — — — — — 113.43K 113.43K 113.43K 1.02M
HRT FINANCIAL LP — 15.24K — — — — — 11.89K 89.97K
MEYER HANDELMAN CO — — — — — 32.97K 32.97K — —
Citadel Advisors — — 20.93K 12.21K — — — — —
TWO SIGMA SECURITIES, LLC — — 11.66K — — — — — 15.12K
Virtu Financial LLC — — — — — 14.26K — — 26.66K
MONTAG A & ASSOCIATES INC — 300 3.00K 3.00K 3.00K — — — —
StoneX Group Inc. — — — — — 11.24K — — —
Bank of America Corp — — — — — 500 500 — —
JONES FINANCIAL COMPANIES LLLP — — 26 26 — — — — —

Download holders (CSV)

FAQ

Which funds hold SLXN?

As of 2026-Q2, 6 institutional funds reported holding SLXN (SILEXION THERAPEUTICS CORP) in SEC 13F filings, with a combined reported value of $42.79K.

How many shares of SLXN do institutions own?

13F filers reported 17.12K shares of SLXN, worth $42.79K in aggregate at the end of 2026-Q2.

Is institutional ownership of SLXN rising or falling?

Share counts moved -54.9% versus the prior quarter — distribution.

Who are the top institutional holders of SLXN?

The largest 13F holders are Wildcat Capital Management, LLC, Warberg Asset Management LLC, HRT FINANCIAL LP, Citadel Advisors, MEYER HANDELMAN CO; the top 25 are ranked at the top of this page.

Who are the major shareholders of SILEXION THERAPEUTICS CORP?

The major shareholders of SILEXION THERAPEUTICS CORP (SLXN) by reported 13F value are Wildcat Capital Management, LLC, Warberg Asset Management LLC, HRT FINANCIAL LP, Citadel Advisors, MEYER HANDELMAN CO, among 17 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own SLXN" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/SLXN/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →